Pharmapack Europe Reveals 2019 Award Winners

Pharmaceutical Technology Editors

Nine award winners from the 2019 edition of Pharmapack Europe, covering innovations across drug delivery, packaging, and materials and components, have been announced by the event organizers.

Nine award winners from the 2019 edition of Pharmapack Europe, covering innovations across drug delivery, packaging, and materials and components, have been announced by the event organizers.

The awards fell into two categories: Exhibitor innovations and health products. In the former there were six winners, with two winners being announced in each of the three fields. The exhibitor winners were as follows:

Best Innovation in Drug Delivery Device

  • Connected Health Platform by Phillips-Medisize

  • Cartridge-based wearable device by Stevanato Group

Best Innovation in Solid Dosage Packaging

  • Push Tab by Huhtamaki Flexible Packaging Germany GmbH & Co.KG

  • IQ-DOSE by Stiplastics Healthcaring

Best Innovation in Packaging Material & Component

  • syriQ BioPure by SCHOTT AG

  • QuickStart Injectables by Aptar Pharma

In the health product category, three winners were announced. Two companies received awards for product eco-design. These companies were UCB PHARMA, co-developer: RONDO, which won for its Cimzia 200 mg/vial lyophilized powder pack, and RPC Bramlage, co-developer: Pierre Fabre Dermo Cosmetiqué (PFDC), which was chosen for its Sterile Cosmetics.

The other winner in the health product category was Medical Brands (co-developer: Vemedia), which received the patient-centric design award for its Excilor 2-in-1 wart treatment.

“I would like to congratulate all nine of the winners at this year’s Pharmapack Awards. They showcased a wide range of industry-changing discoveries in the field of drug delivery, packaging, and automation,” commented Silvia Forroova, brand director at Pharmapack Europe. “But I must also thank our partners-Adelphe and HCPC Europe-for helping to deliver what is now widely seen as a beacon of innovation across Europe. It’s such an exciting time for new products and developments entering the market, but most important are the benefits innovations like these can deliver to patients globally.”

Source: Pharmapack Europe